Use of Crispr on human embryos approved in UK


© iStock

The use of the Crispr gene editing technique on human embryos used in research has been given approval for the first time by authorities in the UK.

Genetic modification techniques have been used in research for many years, but the recently developed Crispr (clustered regularly interspaced short palindromic repeats) tool makes it possible to target genes with more precision.

Permission to use it to modify human embryos has been given to a group led by Kathy Niakan at the Francis Crick Institute in London by the Human Fertilisation and Embryology Authority. The group applied in September 2015 to use Crispr to alter various genes controlling development in very early stage donated embryos (less than seven days old), with the aim of understanding the development process in greater detail. Niakan and colleagues say that their work could help understand some of the factors that lead to pregnancies failing, as well as broader advances in stem cell research.

The technique will be used purely for research purposes, and the embryos will never be implanted. The work is due to start within months.


Related Content

The cutting edge of gene editing

22 January 2016 Feature

news image

The new gene-editing tool Crispr is taking the scientific world by storm, reports Katrina Megget

Crispr conversation starter

21 January 2016 Research

news image

Alan Regenberg talks to Katrina Megget about the ethics of gene editing

Most Commented

New antibiotic picked from nose bacteria

27 July 2016 Research

news image

Discovery suggests human microbiome may be an untapped source of antimicrobial compounds

Perovskite boosts silicon solar cell efficiency

25 November 2015 News and Analysis

news image

Silicon industry will be ‘beating a path to the door’ of inventors, says scientist